Actively Recruiting

Phase Not Applicable
Age: 18Years +
All Genders
NCT05833529

Innovative Cognitive and Behavioral Psychotherapy for Cocaine Use Disorder

Led by Thomas Lehoux · Updated on 2024-06-10

54

Participants Needed

2

Research Sites

104 weeks

Total Duration

On this page

Sponsors

T

Thomas Lehoux

Lead Sponsor

L

Laboratoire de Psychologie des Cognitions (Strasbourg University, France)

Collaborating Sponsor

AI-Summary

What this Trial Is About

Cocaine is the 2nd most used illicit substance in Europe and its use implies numerous health complications as well as an annual social cost of 8.7 G d'€. Classical (picture, video, audio, imagery based or in vivo) cue exposure therapy for substance craving (CET), i.e. the irrepressible and non-voluntary desire to use the substance, failed to prove efficacious in treating substance use disorder. Virtual reality cue exposure therapy for substance craving (VRCET), is more immersive, realistic and controllable, and is suggested as being a more efficacious intervention in reducing craving as compared to classical CET. So far it's still not known, thus the secondary aim of the present randomized and clinical trial is to investigate, whether virtual reality cue exposure is more efficacious, as compared to classical cue exposure, in both eliciting and reducing cocaine craving in a clinical context of CET for cocaine craving. The main study aim to is to investigate whether a VRCET for cocaine craving based cognitivo-behavioral therapy (i.e. VRCET followed by memory focused cognitive therapy) is more efficacious than a behavioural therapy (i.e. classical exposure therapy to craving) in reducing cocaine craving. To do so, 54 voluntary residential patients in treatment for cocaine use disorder will be recruited from the Universitary Hospital Center of Martinique (CHUM, Martinique, France) and Saint-Esprit Hospital Center (CHSE, Martinique, France) and randomly allocated in either a 3 weeks individual experimental treatment (10 meetings of VRET for cocaine craving followed by 5 meetings of memory focused cognitive therapy) or a 3 weeks individual control treatment (15 meetings of pictures based exposure therapy for cocaine craving). Self-reported measures of retrospective (last 14 days) and in virtuo exposure cocaine craving will be collected at the beginning, after 10 days, after 15 days of treatment and 1 month post. Others secondary subjective, urinary and physiological cocaine use related measures will also be collected.

CONDITIONS

Official Title

Innovative Cognitive and Behavioral Psychotherapy for Cocaine Use Disorder

Who Can Participate

Age: 18Years +
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Adults aged 18 or older
  • Diagnosed with cocaine use disorder according to DSM-5 criteria
  • Voluntarily hospitalized and receiving residential treatment for cocaine use disorder at specified hospitals in Martinique
  • Motivated to stop or maintain abstinence from cocaine use
  • Informed of the research and provided free, informed consent
  • Affiliated with a social security scheme
Not Eligible

You will not qualify if you...

  • Current high suicide risk episode
  • Current psychotic syndrome
  • Current mania or hypomania episode
  • Current post-traumatic stress
  • Significant symptoms of cyberkinetosis during virtual reality exposure
  • Other medical conditions that pose danger or prevent protocol compliance (e.g., heart problems, blindness, deafness)
  • Under legal protection such as guardianship or curatorship
  • Refusal to participate in the study
  • Pregnant or breastfeeding women

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 2 locations

1

University Hospital Center of Martinique

Fort-de-France, Martinique, 97261

Actively Recruiting

2

Hospital Center of Saint-Esprit (Martinique)

Saint-Esprit, Martinique, 97270

Not Yet Recruiting

Loading map...

Research Team

T

Thomas LEHOUX, Ph.D. Candidate

CONTACT

J

Jérôme LACOSTE, MD

CONTACT

How is the study designed?

Study Type

INTERVENTIONAL

Masking

NONE

Allocation

RANDOMIZED

Model

PARALLEL

Primary Purpose

TREATMENT

Number of Arms

2

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here